Precigen’s (PGEN) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report sent to investors on Thursday,Benzinga reports. HC Wainwright currently has a $6.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s FY2027 earnings at $0.18 EPS, FY2028 earnings at $0.40 EPS and […]
HC Wainwright reaffirmed their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report sent to investors on Thursday,Benzinga reports. HC Wainwright currently has a $6.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s FY2027 earnings at $0.18 EPS, FY2028 earnings at $0.40 EPS and […]
